Search

Low-complexity ultrasound systems are increasingly desired for both wearable, point-of-care ultrasound and high-end massive-channel ultrasound for 3-D matrix imaging. However, the imaging capabilities, including spatial resolution and contrast, could suffer as low complexity systems are pursued, which remains as an unresolved tradeoff. To mitigate this limitation, this study revisits the general structures of analog and digital beamformers and introduces a hybrid approach, referred to as analog-digital hybrid beamforming, to implement efficient ultrasound systems. The suggested hybrid beamforming takes two stages sequentially, where the first analog stage partially beamforms M-channel RF signals to N sum-out data (i.e., M-to-N beamforming), and the second digital stage beamforms N partial sums to single final beamformed data (i.e., N-to-1 beamforming). Our approach was systematically designed and implemented with only four major integrated circuits, which was capable of driving full 64-channel transmission and reception. The developed system was demonstrated with a customized 64-channel 1-D phased array using a commercial tissue mimicking phantom. From the phantom imaging results, signal-to-noise ratio, contrast-to-noise ratio, and full beam width at half maximum values were quantitatively evaluated. The demonstrated results indicate that the analog-digital hybrid beamforming can be applied to any type of array for sophisticated 3-D imaging and tiny wearable ultrasound applications. [ABSTRACT FROM AUTHOR]

Perfluorocarbon nanodroplets (PFCnDs) are sub-micrometer emulsions composed of a surfactant-encased perfluorocarbon (PFC) liquid and can be formulated to transiently vaporize through optical stimulation. However, the factors governing repeated optical droplet vaporization (ODV) have not been investigated. In this study, we employ high-frame-rate ultrasound (US) to characterize the ODV thresholds of various formulations and imaging parameters and identify those that exhibit low vaporization thresholds and repeatable vaporization. We observe a phenomenon termed "preconditioning", where initial laser pulses generate reduced US contrast that appears linked with an increase in nanodroplet size. Variation in laser pulse repetition frequency is found not to change the vaporization threshold, suggesting that "preconditioning" is not related to residual heat. Surfactants (bovine serum albumin, lipids, and zonyl) impact the vaporization threshold and imaging lifetime, with lipid shells demonstrating the best performance with relatively low thresholds (21.6 ± 3.7 mJ/cm2) and long lifetimes (t1/2 = 104 ± 21.5 pulses at 75 mJ/cm2). Physiological stiffness does not affect the ODV threshold and may enhance nanodroplet stability. Furthermore, PFC critical temperatures are found to correlate with vaporization thresholds. These observations enhance our understanding of ODV behavior and pave the way for improved nanodroplet performance in biomedical applications. [ABSTRACT FROM AUTHOR]

Laser-activated perfluorocarbon nanodroplets (PFCnDs) are emerging phase-change contrast agents that showed promising potential in ultrasound and photoacoustic (US/PA) imaging. Unlike monophase gaseous microbubbles, PFCnDs shift their state from liquid to gas via optical activation and can provide high US/PA contrast on demand. Depending on the choice of perfluorocarbon core, the vaporization and condensation dynamics of the PFCnDs are controllable. Therefore, these configurable properties of activation and deactivation of PFCnDs are employed to enable various imaging approaches, including contrast-enhanced imaging and super-resolution imaging. In addition, synchronous application of both acoustic and optical pulses showed a promising outcome vaporizing PFCnDs with lower activation thresholds. Furthermore, due to their sub-micrometer size, PFCnDs can be used for molecular imaging of extravascular tissue. PFCnDs can also be an effective therapeutic tool. As PFCnDs can carry therapeutic drugs or other particles, they can be used for drug delivery, as well as photothermal and photodynamic therapies. Blood barrier opening for neurological applications was recently demonstrated with optically-triggered PFCnDs. This paper specifically focuses on the activation and deactivation properties of laser-activated PFCnDs and associated US/PA imaging approaches, and briefly discusses their theranostic potential and future directions. [ABSTRACT FROM AUTHOR]